Evaluation of the Superion™ IDS device for lumbar spinal stenosis outcomes
A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)
This study is testing if the Superion™ device can help relieve pain in the legs, buttocks, and groin for people over 45 with lumbar spinal stenosis during everyday activities.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 214 (estimated) |
| Ages | 45 Years and up |
| Sex | All |
| Sponsor | Boston Scientific Corporation Industry-sponsored |
| Drugs / interventions | cart |
| Locations | 27 sites (Carlsbad, California and 26 other locations) |
| Trial ID | NCT04192591 on ClinicalTrials.gov |
What this trial studies
This evaluation aims to gather real-world outcomes of the Superion™ Interspinous Decompression System (IDS) when used in routine clinical practice for patients with lumbar spinal stenosis. The study will assess the effectiveness of the device in alleviating symptoms such as leg, buttock, and groin pain, particularly in activities that require flexion. Participants will be monitored over a five-year period to determine the long-term benefits and safety of the device. The study will include patients aged 45 and older who meet specific diagnostic criteria and are able to provide informed consent.
Who should consider this trial
Good fit: Ideal candidates for this evaluation are individuals aged 45 and older with a diagnosis of degenerative lumbar spinal stenosis and persistent pain that is relieved by flexion activities.
Not a fit: Patients with conditions other than lumbar spinal stenosis or those who do not experience pain relief through flexion activities may not benefit from this evaluation.
Why it matters
Potential benefit: If successful, this evaluation could provide valuable insights into the long-term effectiveness of the Superion™ IDS device, potentially improving treatment options for patients with lumbar spinal stenosis.
How similar studies have performed: Previous studies on similar interspinous devices have shown promising outcomes, indicating potential for success in this evaluation.
Eligibility criteria
Show full inclusion / exclusion criteria
Key Inclusion Criteria: * 45 years of age or older when written informed consent is obtained * Persistent leg/buttock/groin pain, with or without back pain that is consistently relieved by flexion activities (example: sitting or bending over a shopping cart). * Diagnosis of degenerative spinal stenosis of the lumbar spine, defined as the narrowing of the midline sagittal spinal canal (central) and/or narrowing between the facet superior articulating process (SAP), the posterior vertebral margin (lateral access), and the nerve root canal (foraminal). * Subject signed a valid, IRB-approved informed consent form (ICF) provided in English. * Subjects, who, in the opinion of the Clinical Investigator, are able to understand this clinical investigation, cooperate with the investigational procedures and are willing to return for all the required post-treatment follow-ups. * Able to independently read and complete all questionnaires and assessments provided in English Key Exclusion Criteria: * Axial back pain only. * Fixed motor deficit in lower extremity(ies) due to LSS. * Has any pain-related diagnosis, medical/psychological condition or external factors that, in the investigator's medical judgment, might confound reporting of study outcomes (e.g. history of pelvic pain, anginal pain, chronic migraine, involved in litigation, workmen's compensation, spinal tumor) * Participating (or intends to participate) in another drug or device clinical trial that may influence the data that will be collected for this study
Where this trial is running
Carlsbad, California and 26 other locations
- Coastal Research Institute, LLC — Carlsbad, California, United States (Terminated)
- MarinHealth Spine Institute — Larkspur, California, United States (Recruiting)
- Vitamed Research — Rancho Mirage, California, United States (Recruiting)
- Pacific Research Institute — Santa Rosa, California, United States (Withdrawn)
- IPM Medical Group Inc. — Walnut Creek, California, United States (Recruiting)
- Holy Cross Hospital — Fort Lauderdale, Florida, United States (Recruiting)
- The Orthopaedic Institute — Gainesville, Florida, United States (Recruiting)
- Florida Pain Management — Sebastian, Florida, United States (Withdrawn)
- Alliance Spine and Pain Centers — Atlanta, Georgia, United States (Terminated)
- Centurion Spine and Pain — Waycross, Georgia, United States (Terminated)
- North Idaho Day Surgery — Post Falls, Idaho, United States (Recruiting)
- Rush University Medical Center — Chicago, Illinois, United States (Recruiting)
- Ascension Alexian Brothers — Elk Grove Village, Illinois, United States (Recruiting)
- University of Kansas Hospital — Kansas City, Kansas, United States (Recruiting)
- Neuroscience Research Center, LLC — Overland Park, Kansas, United States (Recruiting)
- Brigham and Women's Hospital — Boston, Massachusetts, United States (Recruiting)
- Michigan Pain Specialists — Ypsilanti, Michigan, United States (Terminated)
- Weill Cornell Medical University — New York, New York, United States (Recruiting)
- Pacific Sports and Spine, LLC — Eugene, Oregon, United States (Recruiting)
- Spinal Diagnostics — Tualatin, Oregon, United States (Withdrawn)
- Center for Interventional Pain and Spine — Lancaster, Pennsylvania, United States (Terminated)
- SC Pain and Spine Specialists — Murrells Inlet, South Carolina, United States (Recruiting)
- Central Texas Pain Institute — Killeen, Texas, United States (Withdrawn)
- Precision Spine Care — Tyler, Texas, United States (Recruiting)
- Swedish Health Services — Seattle, Washington, United States (Recruiting)
- Northwest Pain Care — Spokane, Washington, United States (Terminated)
- The Spine and Nerve Center of Saint Francis Hospital — Charleston, West Virginia, United States (Recruiting)
Study contacts
- Study coordinator: Ann Yamano
- Email: BSNClinicalTrials@bsci.com
- Phone: 855-213-9890
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.